Literature DB >> 21674642

Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease.

Tito Calì1, Denis Ottolini, Marisa Brini.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disease characterized by a loss of dopaminergic neurons in the substantia nigra pars compacta (SNPC) and the presence of intracytoplasmatic inclusions known as Lewy bodies, largely composed of alpha-synuclein (α-syn). PD is a multifactorial disease and its etiology remains largely elusive. Although more than 90% of the cases are sporadic, mutations in several nuclear encoded genes have been linked to the development of autosomal recessive and dominant familial parkinsonian syndromes (Bogaerts et al. (2008) Genes Brain Behav 7, 129-151), enhancing our understanding of biochemical and cellular mechanisms contributing to the disease. Many cellular mechanisms are thought to be involved in the dopaminergic neuronal death in PD, including oxidative stress, intracellular Ca(2+) homeostasis impairment, and mitochondrial dysfunctions. Furthermore, endoplasmic reticulum (ER) stress together with abnormal protein degradation by the ubiquitin proteasome system is considered to contribute to the PD pathogenesis. This review covers all the aspects related to the molecular mechanisms underlying the interplay between mitochondria, ER, and proteasome system in PD-associated neurodegeneration.
Copyright © 2011 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21674642     DOI: 10.1002/biof.159

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  42 in total

1.  Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1.

Authors:  Pamela Valdés; Gabriela Mercado; Rene L Vidal; Claudia Molina; Geoffrey Parsons; Felipe A Court; Alexis Martinez; Danny Galleguillos; Donna Armentano; Bernard L Schneider; Claudio Hetz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-21       Impact factor: 11.205

2.  Parkinson's disease: don't mess with calcium.

Authors:  Mark P Mattson
Journal:  J Clin Invest       Date:  2012-03-26       Impact factor: 14.808

Review 3.  TRPC Channels and Parkinson's Disease.

Authors:  Pramod Sukumaran; Yuyang Sun; Anne Schaar; Senthil Selvaraj; Brij B Singh
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

4.  Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD.

Authors:  Silke Nuber; Daniel Tadros; Jerel Fields; Cassia Rose Overk; Benjamin Ettle; Kori Kosberg; Michael Mante; Edward Rockenstein; Margarita Trejo; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2014-02-08       Impact factor: 17.088

Review 5.  The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease.

Authors:  Yan Shen; Xingfang Guo; Chao Han; Fang Wan; Kai Ma; Shiyi Guo; Luxi Wang; Yun Xia; Ling Liu; Zhicheng Lin; Jinsha Huang; Nian Xiong; Tao Wang
Journal:  Cell Mol Life Sci       Date:  2017-06-16       Impact factor: 9.261

6.  Pinocembrin Attenuates Mitochondrial Dysfunction in Human Neuroblastoma SH-SY5Y Cells Exposed to Methylglyoxal: Role for the Erk1/2-Nrf2 Signaling Pathway.

Authors:  Marcos Roberto de Oliveira; Alessandra Peres; Gustavo Costa Ferreira
Journal:  Neurochem Res       Date:  2016-12-21       Impact factor: 3.996

7.  Gastrodin inhibits glutamate-induced apoptosis of PC12 cells via inhibition of CaMKII/ASK-1/p38 MAPK/p53 signaling cascade.

Authors:  Genling Jiang; Haiyun Wu; Yuqin Hu; Jun Li; Qinling Li
Journal:  Cell Mol Neurobiol       Date:  2014-03-12       Impact factor: 5.046

8.  Pretreatment of chemically-synthesized Aβ42 affects its biological activity in yeast.

Authors:  Afsaneh Porzoor; Joanne M Caine; Ian G Macreadie
Journal:  Prion       Date:  2014       Impact factor: 3.931

9.  Pinocembrin Provides Mitochondrial Protection by the Activation of the Erk1/2-Nrf2 Signaling Pathway in SH-SY5Y Neuroblastoma Cells Exposed to Paraquat.

Authors:  Marcos Roberto de Oliveira; Alessandra Peres; Clarissa Severino Gama; Simone Morelo Dal Bosco
Journal:  Mol Neurobiol       Date:  2016-10-01       Impact factor: 5.590

10.  Axonopathy in an α-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated α-synuclein.

Authors:  Dora Games; Peter Seubert; Edward Rockenstein; Christina Patrick; Margarita Trejo; Kiren Ubhi; Benjamin Ettle; Majid Ghassemiam; Robin Barbour; Dale Schenk; Silke Nuber; Eliezer Masliah
Journal:  Am J Pathol       Date:  2013-01-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.